Delivery Order SPE2DP25D0003-SPE2DP25F4412
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccines and medical supplies. The contract, valued at $1,336,273.60, is for the delivery of influenza virus vaccines. The contract has an ultimate completion date of September 26, 2025 and does not have a set-aside designation. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical...
- This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer of vaccines and medical supplies, for the provision of influenza virus vaccines. The contract has a ceiling value of $983,915.20 and is a firm fixed price delivery order, with an ultimate completion date of September 26, 2025. The contract is awarded by the Defense Logistics Agency, a component of the Department of Defense, and is not set aside for any specific business category....
- This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, by the Defense Logistics Agency (DLA) for the delivery of influenza virus vaccines. The contract has a ceiling value of $23,926.32 and an ultimate completion date of April 18, 2025. The contract is a delivery order, with a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) vehicle held by Sanofi Pasteur Inc. with various federal agencies,...
- This is a $6,025,705.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of influenza virus vaccines. The contract has an ultimate completion date of September 26, 2025 and does not utilize any set-aside designations. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical countermeasures to various U.S. federal government agencies,...
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a $2,990.79 firm fixed-price delivery order to Sanofi Pasteur Inc. for influenza virus vaccine on April 15, 2025. The contract, with an ultimate completion date of April 18, 2025, does not utilize any set-aside designation. Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer headquartered in Swiftwater, Pennsylvania, is a critical supplier of vaccines and medical countermeasures to multiple federal...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency to Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer, for the provision of influenza virus vaccines. The contract has a ceiling value of $2,794,325.82 and a period of performance through November 15, 2016. Sanofi Pasteur Inc. has been awarded numerous indefinite delivery vehicles (IDVs) from various federal agencies, including a $5.87 billion IDIQ from the HHS Office of the Assistant Secretary for...
- This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the production of influenza virus vaccines. The contract, awarded by the Medical Supply Chain division of the Defense agency, is a delivery order with a firm fixed price of $3,150,107.50 and an ultimate completion date of October 13, 2023. The contract does not have a set-aside designation. Sanofi Pasteur Inc. is a major supplier of vaccines and medical countermeasures to various...
- This is a firm fixed price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of vaccines and pharmaceuticals. The contract, valued at $2,794,386.42, is for the provision of influenza virus vaccines. The contract does not have a set-aside designation and the place of performance is Sanofi Pasteur's facility in Swiftwater, Pennsylvania. Sanofi Pasteur Inc. is an experienced...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer of vaccines and medical supplies. The $74,400.00 firm fixed price delivery order contract is for the provision of influenza virus vaccines. The contract does not have a set-aside designation. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical countermeasures to various U.S. federal government agencies, including the Centers...
- The U.S. Department of Defense Medical Supply Chain has awarded a $1,153.52 firm fixed-price purchase order to Sanofi Pasteur Inc. for influenza virus vaccine. The award, issued on October 2, 2025, with an ultimate completion date of October 7, 2025, represents a small-value delivery order with no set-aside designation. Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer headquartered in Swiftwater, Pennsylvania, serves as the prime contractor and will fulfill this requirement...
- SPE2DP25D0003Indefinite Delivery Contract
- SPE2DP25D0003-SPE2DP25F4412Delivery Order
This is a Delivery Order (DO) contract awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer of vaccines and medical supplies. The contract is for the delivery of influenza virus vaccines, with an ultimate completion date of September 26, 2025 and a ceiling value of $2,317,562.40. The contract is a Firm Fixed Price (FFP) contract and does not utilize any set-aside designations. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical countermeasures to various U.S. federal government agencies, including the Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), Department of Defense (DoD), and Department of Health and Human Services (HHS). The company holds multiple significant Indefinite Delivery Contracts (IDCs) across these agencies, including a $1.99 billion contract with the CDC for the Vaccines for Children (VFC) program and a $47.55 million influenza vaccine contract with the VA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3m | 3/5/25 |